Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Failure”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02829008
What this trial is testing

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)Looking for participantsNCT07065435
What this trial is testing

RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Who this might be right for
HER2 + Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 74
Not applicableLooking for participantsNCT04291378
What this trial is testing

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

Who this might be right for
Early Breast CancerRadiation Associated Cardiac Failure
Danish Breast Cancer Cooperative Group 1,502
Not applicableUnknownNCT04003558
What this trial is testing

Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)

Who this might be right for
Breast Neoplasm FemaleEarly-stage Breast CancerRadiomics+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,500
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Early research (Phase 1)Looking for participantsNCT06817590
What this trial is testing

Nucleoside Therapy in Patients With Telomere Biology Disorders

Who this might be right for
Telomere Biology DisordersDyskeratosis CongenitaRevesz Syndrome+4 more
Suneet Agarwal 36
Post-approval studies (Phase 4)Study completedNCT06466421
What this trial is testing

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Who this might be right for
Uremic PruritusChronic Kidney Disease-associated PruritusHemodialysis+3 more
Tanta University 60
Not applicableStudy completedNCT01044810
What this trial is testing

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

Who this might be right for
Treatment Failure, HIV or AIDSCD4 Cell Counts
Bamrasnaradura Infectious Diseases Institute 559
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Not applicableLooking for participantsNCT03987633
What this trial is testing

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Who this might be right for
Atrial FibrillationCoronary Heart DiseaseCardiovascular Diseases+19 more
Future Genetics Limited 200,000
Not applicableUnknownNCT01657513
What this trial is testing

TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

Who this might be right for
Psoriasis
University Hospital, Gentofte, Copenhagen 60
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT00570921
What this trial is testing

Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure

Who this might be right for
Breast Cancer
Mara Chambers 33
Not applicableUnknownNCT04446936
What this trial is testing

Comparing Different Surgical Techniques for Coverage of Pressure Ulcer

Who this might be right for
Pressure Ulcer
University Hospital, Montpellier 200
Large-scale testing (Phase 3)Study completedNCT01004432
What this trial is testing

Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

Who this might be right for
ArthritisArthritis, RheumatoidAutoimmune Diseases
Janssen Biotech, Inc. 433
Not applicableStudy completedNCT06139588
What this trial is testing

Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction

Who this might be right for
Breast Implant; ComplicationsBreast Implant InfectionImplant Capsular Contracture+3 more
European Institute of Oncology 146
Testing effectiveness (Phase 2)Study completedNCT01231659
What this trial is testing

Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Postmenopausal WomenLocally Advanced Metastatic Breast CancerMetastatic Breast Cancer
Novartis Pharmaceuticals 72
Testing effectiveness (Phase 2)Looking for participantsNCT03579875
What this trial is testing

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Who this might be right for
Fanconi AnemiaSevere Aplastic AnemiaMyelodysplastic Syndromes+5 more
Masonic Cancer Center, University of Minnesota 48
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Next Page